Endogenous metals such as zinc may contribute to ␤-amyloid (A␤) aggregation and hence the plaque formation. In the present study, we examined brains of four Swedish mutant amyloid precursor protein (APP) transgenic mice at 12 months of age for histochemically reactive zinc in the plaques. Here, we report that all the Congo red (ϩ) mature plaques contained chelatable zinc, as demonstrated by staining with the zinc-specific fluorescent dye 6-methoxy-8-quinolyl-para-toluenesulfonamide (TSQ). On the other hand, Congo red (Ϫ) preamyloid A␤ deposits were not stained with TSQ. Interestingly, although cerebellum contained similar degree of preamyloid A␤ deposits as cerebral cortex, it was completely devoid of Congo red-or TSQ-stained mature plaques. Although zinc from plaques was only slowly and partially removed by a specific zinc remover, dithizone, treatment of brain sections with heparinase-III, which degrades heparan sulfate proteoglycan (HSPG), another major constituent of plaques, greatly fastened the zinc removal with dithizone.
One of the hallmark pathological features of Alzheimer's disease (AD) is the accumulation of amyloid plaques in the brain. The main component of the amyloid plaque is the peptide fragment of 39 -43 amino acid residues (A␤), derived from ␤-amyloid precursor protein (APP) of 695-771 amino acids (Kang et al., 1987) . Recent studies suggest that abnormal processing of APP and accumulation of amyloid plaques may play a causal role in the pathogenesis of AD. First, all the identified mutant genes causing familial AD (APP and presenilin-1 and -2) have been shown to increase A␤ production (Price and Sisodia, 1998) . Second, transgenic mice overexpressing human mutant APP develop not only the accumulation of amyloid plaques but also deficits in learning (Games et al., 1995; Hsiao et al., 1996) . Finally, aggregated A␤ induces neuronal death in cultures (Pike et al., 1993) .
In light of evidence that A␤ accumulation and plaque formation play a pivotal role in the AD pathogenesis, understanding the precise mechanisms of the process may be crucial for contemplating effective treatments against AD. Recently, Bush et al. (1994a) and Atwood et al. (1998) showed that zinc and copper promote A␤ aggregation in test tube conditions and suggested that these endogenous metals may contribute to the process of the plaque formation. Corroborating this hypothesis, they showed that metal chelators increase extraction of A␤ from the human AD brains (Cherny et al., 1998) . Furthermore, examination of AD brains revealed that chelatable zinc is present in plaques and tangles (Suh et al., 1998) . Although these data support the metal, in particular zinc, hypothesis in plaque formation, it is difficult to test this directly in human patients. Cell membrane-permeant metal chelators such as N, N, NЈ, ethylenediamine are highly toxic to neurons (Ahn et al., 1998) . On the other hand, nontoxic extracellular metal chelators such as Ca-EDTA do not cross the blood-brain barrier and hence should be applied into parenchyme or CSF. Because this requires invasive procedures, careful animal experiments are warranted before testing it in human patients. For this reason, we examined whether zinc is identifiable in plaques of transgenic mice overexpressing the Swedish mutant APP (Hsiao et al., 1996) .
MATERIALS AND METHODS
Transgenic mice. Transgenic mice overexpressing Swedish mutant APP (Tg2576) (Hsiao et al., 1996) were generous gift from Dr. K . Hsiao (University of Minnesota, Minneapolis, M N). For the present study, four female Tg2576 mice at 12 months of age were used. According to the report of Hsiao et al. (1996) , ␤-amyloid plaques begin to appear at 9 months after birth in the Tg2576 mouse brain.
T issue preparation and Congo red staining. Brains of Tg2576 mice were harvested and immediately frozen in dry ice. Coronal brain sections of 10 m thickness were obtained using a cryostat (Leica, Nussloch, Germany) and mounted on glass slides. Plaques were identified by staining brain sections with Congo red. After staining in Mayer's hematoxylin solution for 10 min, brain sections were rinsed in tap water for 5 min and incubated in alkaline sodium chloride solution for 20 min. Brain sections were then stained with alkaline Congo red solution (0.2% in 80% ethanol saturated with sodium chloride; Sigma, St. L ouis, MO) and washed in absolute ethanol. Congo red-stained sections were observed under light microscope (conventional and polarized).
Immunoc ytochemistr y. A␤ deposits inside and outside congophilic plaques were visualized immunocytochemically with mouse monoclonal antibody 4G8 (Senetek, St. L ouis, MO) specific for A␤17-24. Immunocytochemistry was performed using the avidin -biotin -horseradish peroxidase method (Vector Laboratories, Burlingame, CA). Briefly, frozen brain sections were blocked with horse serum and immunoreacted overnight with 4G8 at 1:1000 dilution. After reaction with biotinylated secondary antibody (horse anti-mouse IgG), sections were treated with avidin -horseradish peroxidase solution. After thorough rinsing with PBS, sections were incubated in solution containing 0.015% diaminobenzidine and 0.001% hydrogen peroxide.
To immunocytochemically verif y the degradation of heparan sulfate proteoglycan (HSPG) in plaques after treatment with heparinase-III, anti-⌬-heparan sulfate antibody 3G10 (Seikagaku, Tokyo, Japan) specific for heparinase-digested heparan sulfate side chains was used (1:50).
Fluorescent zinc staining. To examine the presence of chelatable zinc in plaques, brain sections were stained with 6-methoxy-8-quinolyl-paratoluenesulfonamide (TSQ) (Frederickson et al., 1987) . Without fixation, frozen sections were immersed for 90 sec in TSQ solution (4.5 M; Molecular Probes, Eugene, OR) in 140 mM sodium barbital and 140 mM sodium acetate buffer, pH 10. After washing with normal saline, TSQ fluorescence was examined under a fluorescence microscope with an ultraviolet filter (excitation, 355-375 nm; dichroic, 380 nm; barrier, 420 nm).
Removal of tissue zinc with dithizone. Dithizone specifically removes zinc from tissue (Koh et al., 1996) . Brain sections were immersed in 10 mM dithizone for 5 min at room temperature. After rinsing with normal saline, brain sections were examined for TSQ fluorescence.
Heparinase-III treatment. To digest HSPG in brain sections, frozen brain sections were incubated at 37°C for 2 hr in heparinase-IIIcontaining PBS (2 U in 200 l; Sigma). The enzyme reaction was terminated by rinsing brain sections multiple times with normal saline. 
RESULTS
Brains of four Swedish mutant APP transgenic mice were examined at 12 months of age, when they developed numerous congophilic plaques with apple green birefringence in cerebral cortex and hippocampus, as previously reported (Hsiao et al., 1996) (Fig.  1 A,B) . On the other hand, immunocytochemical staining of an adjacent section with anti-A␤17-24 antibody recognized not only congophilic plaques but also more widespread preamyloid A␤ deposits (Fig. 1C) . TSQ staining revealed that all the congophilic plaques contained chelatable zinc (Fig. 1 D) . However, preamyloid A␤ deposits were not stained for zinc with TSQ. Changing the order of staining, first TSQ and then Congo red, did not alter the correlation, ruling out the possibility that zinc fluorescence is merely an artifact of Congo red staining.
In contrast to forebrain, cerebellum lacks synaptic zinc (Frederickson, 1989 ; Fig. 2 B) . Consistent with the hypothesis that synaptic zinc may contribute to plaque formation, cerebellum contained neither Congo red-stained (Fig. 2 A) nor TSQ-stained (Fig. 2 B) plaques. However, cerebellum still exhibited a substantial amount of preamyloid A␤ deposits (Fig. 2C) , as did cortex and hippocampus.
Interestingly, treatment of plaques with a specific zinc remover, dithizone (10 mM) (Koh et al., 1996) , for 5 min, which abolished background zinc fluorescence presumably in presynaptic vesicles, did not much reduce the fluorescence in plaques (Fig. 3B) . This suggested that some of the zinc in plaques was not easily accessible for dithizone. Because HSPG, another major constituent of plaques, may contribute to A␤ aggregation (Snow et al., 1988; Brunden et al., 1993) , we examined whether it is involved in holding zinc. The treatment of adjacent brain sections of the above with heparinase-III for 2 hr degraded HSPG in plaques, as evidenced by the emergence of immunoreactivity to an antibody (3G10) specific for digested heparan sulfate side chains (Fig. 3E) . The heparinase-III treatment rendered zinc removal by dithizone much faster. Subsequent to the heparinase-III treatment, 5 min exposure to dithizone completely abolished TSQ fluorescence in the plaques (Fig. 3C, compare with B) . In contrast, even 30 min exposure to 10 mM dithizone in naïve tissue only partially removed zinc in plaques (Fig. 3D ). This finding suggests that HSPG indeed contributes to holding zinc in plaques. However, despite complete removal of zinc, plaques were still stained with anti-A␤ antibody (Fig. 3F ) or Congo red (Fig. 3G) .
DISCUSSION
Our findings have demonstrated that TSQ-stainable zinc is invariably present in mature congophilic amyloid plaques but not in preamyloid A␤ deposits of the Swedish mutant APP transgenic mice. Combined with a report showing that human AD brains also contain chelatable zinc in plaques (Suh et al., 1998) , the present results suggest that the presence of chelatable zinc may be a universal feature of mature congophilic plaques. Because TSQ and dithizone are specific for zinc, the fluorescent signal in plaques has likely originated from zinc. With the histochemical methods used in the present study, however, we cannot rule out a possible additional contribution of copper in the plaque formation (Atwood et al., 1998) . In addition, because TSQ is a dye with relatively low affinity for zinc (Frederickson et al., 1987) , it remains a possibility that low-level or tightly bound zinc is present even in preamyloid A␤ deposits. In any case, the fact that a large amount of chelatable zinc is invariably present in mature congophilic plaques supports the hypothesis that endogenous zinc contributes to the maturation of A␤ plaques (Bush et al., 1994a) . It has been shown that zinc binds to A␤ with high and low affinities, indicating the presence of specific binding sites (Bush et al., 1994b) .
Interestingly, cerebellum lacking synaptic vesicle zinc (Frederickson, 1989 ), but containing similar amounts of tissue copper (Sato et al., 1994) , does not develop plaques in transgenic mice (present study) as well as in human AD brains (Joachim et al., 1989) , even if cerebellum has substantial preamyloid A␤ deposits. Although these findings argue that zinc accumulation is unlikely only a result of its nonspecific binding to a preformed ␤-pleated sheet, the present study cannot completely rule out this possibility. However, zinc preferentially binds to soluble A␤ (␣-helical form) (Huang et al., 1997) . Furthermore, metal binding may promote conformational changes of A␤ to ␤-pleated sheet (Vyas Figure 2 . A, Congo red staining of cerebellum revealed no congophilic plaque. B, No TSQ-stainable structure, plaque or presynaptic zinc, was found in cerebellum. C, Anti-A␤ antibody revealed similar amounts of preamyloid A␤ deposits (arrows) in cerebellum as in cerebral cortex (Fig.  1 C) . Scale bars, 500 m.
and Duff y, 1995). These data favor the idea that the zinc binding may be a trigger for the conformation change of A␤.
Further supporting the involvement of synaptic zinc rather than the ambient submicromolar zinc or copper in extracellular fluid (Bush et al., 1994a) in the maturation of A␤ plaques is the evidence that 100 M concentrations of zinc are needed to promote A␤ aggregation (Esler et al., 1996) . At the peak of neuronal activity, such high concentrations of zinc can be attained by the release of synaptic zinc (Assaf and Chung, 1984) .
In addition to A␤, our findings suggest that HSPG may be also involved in the zinc binding. Heparin and HSPG contain metalbinding domains (Whitfield and Sarkar, 1992) . A recent study showed that the presence of zinc could increase in the APP affinity for heparin (Multhaup et al., 1995) . Hence, zinc may play a role in linking A␤ and HSPG to form dense congophilic plaques in AD.
The APP transgenic mice seem to be an ideal model to directly test the hypothesis that endogenous synaptic zinc is necessary for the plaque formation. For example, determining effects of metal chelators administered into the brain or C SF during the time window of the plaque formation in these mice (Ն9 months of age) may be revealing. Additionally, application of zinc into cerebellum of the Swedish APP transgenic mice, where preamyloid A␤ deposits are abundant but plaques are lacking, may provide a parallel clue to this theory. . Five minutes of dithizone treatment abolished background zinc staining but only a fraction of zinc staining in plaques. After 2 hr of treatment of an adjacent section with heparinase-III, however, the same dithizone treatment (5 min, 10 mM) completely removed all the zinc ( C). In contrast, even 30 min of treatment with 10 mM dithizone did not completely remove the TSQ fluorescence in the plaque ( D). E, After treatment for 2 hr with heparinase-III, the antibody specific for digested heparan sulfate side chains (3G10) stained plaques, indicating that HSPG was degraded with the enzyme treatment. TSQ staining was not altered by heparinase treatment alone. F, A brain section was stained with anti-A␤ antibody after complete removal of zinc (heparinase-III and dithizone treatments). Although zinc was completely removed (C), the immunoreactivity of plaques to 4G8 did not change. G, Plaques retained stainability to Congo red after the complete removal of zinc. Scale bars, 500 m.
